The Scientific Leadership Council of the Pulmonary Hypertension Association

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

• Robyn J. Barst, MD, SLC Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, New York

• David B. Badesch, MD, SLC Vice-Chair, Chair, Nominations Committeee, University of Colorado Health Sciences Center, Denver, Colorado

• Raymond L. Benza, MD, University of Alabama, Birmingham, Alabama

• Richard N. Channick, MD, UCSD Medical Center, San Diego, California

• Ramona Doyle, MD, Vera M. Wall Center for Pulmonary Vascular Disease, Palo Alto, California

• C. Gregory Elliott, MD, LDS Hospital, University of Utah School of Medicine, Salt Lake City, Utah

• Karen Fagan, MD, University of Colorado Health Sciences Center, Denver, Colorado

• Adaani Frost, MD, Baylor College of Medicine, Houston, Texas

• Sean Gaine, MD, PhD, Mater Misericordiae Hospital, Dublin, Ireland

• Nazzareno Galiè, MD, Universita di Bologna, Bologna, Italy

• Nicholas Hill, MD, Division of Pulmonary, Critical Care and Sleep Medicine, Tufts-New England Medical Center, Boston, Massachusetts

• Marc Humbert, MD, Hopital Antoine Beclere, Clamart, France

• Dunbar Ivy, MD, University of Colorado, Denver, Colorado

• Michael J. Krowka, MD, Mayo Clinic, Rochester, Minnesota

• David Langleben, MD, Jewish General Hospital, Montreal, Quebec, Canada

• James E. Loyd, MD, Vanderbilt University Medical Center, Nashville, Tennessee

• Michael McGoon, MD, Pulmonary Hypertension Clinic/Mayo Clinic, Rochester, Minnesota

• Vallerie V. McLaughlin, MD, University of Michigan Health System, Ann Arbor, Michigan

• John H. Newman, MD, Vanderbilt Medical School, Nashville, Tennessee

• Ronald J. Oudiz, MD, Liu Center for Pulmonary Hypertension, Harbor-UCLA Medical Center, Torrance, California

• Marlene Rabinovitch, MD, Stanford University School of Medicine, Stanford, California

• Ivan M. Robbins, MD, Chair, Consensus Committee, Vanderbilt University, Nashville, Tennessee

• Lewis J. Rubin, MD, Chair, Research Committee, University of California at San Diego, San Diego, California

• Julio Sandoval, MD, Cardiopulmonary Department, National Institute of Cardiology of Mexico, Tlalpan, Mexico

• James Seibold, MD, University of Michigan Health System, Ann Arbor, Michigan

• Victor E. Tapson, MD, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina

Liaisons

• Natalie Kitterman, RN, BSN, PH Resource Network Chair, Salt Lake City, Utah

• JoAnne Sperando Schmidt, Patient Liaison

• Carol E. Vreim, PhD, Division of Lung Diseases, NHBLi, Bethesda, Maryland

Emeritus Members

• Bruce H. Brundage, MD, St. Charles Medical Center-Bend, Bend, Oregon

• Alfred P. Fishman, MD, University of Pennsylvania Health System, Philadelphia, Pennsylvania

The Mission of the Scientific Leadership Council is to provide medical and scientific guidance and support to the PHA by:

• Developing and disseminating knowledge for diagnosing and treating pulmonary hypertension

• Advocating for patients with pulmonary hypertension

• Increasing involvement of basic and clinical researchers and practitioners